Effects of zoledronic acid and docetaxel on small GTP-binding proteins in prostate cancer

被引:4
作者
Jones, Rachel M. [1 ]
Morgan, Claire [2 ]
Bertelli, Gianfilippo [3 ]
机构
[1] Velindre Canc Ctr, Dept Gynaecol, Cardiff CF14 2TL, S Glam, Wales
[2] Swansea Univ, Coll Med, Swansea SA2 8PP, W Glam, Wales
[3] Singleton Hosp, South West Wales Canc Inst, Swansea SA2 8QA, W Glam, Wales
关键词
Castration resistant; Prostate cancer; RhoA; Ras; Zoledronic acid; Docetaxel; FARNESYL TRANSFERASE INHIBITORS; MEMBRANE LOCALIZATION; MEVALONATE PATHWAY; APOPTOSIS; BISPHOSPHONATE; CELLS; RAS; GROWTH; TAXOL; RHOA;
D O I
10.1007/s13277-015-3140-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Increasingly, in castration-resistant prostate cancer, patients are often treated with docetaxel and the bisphosphonate zoledronic acid concurrently, yet there is still a paucity in the literature regarding the molecular basis of how this drug combination works. The study was performed on the hormone-resistant cell line PC-3. Cells were treated with clinically relevant concentrations of docetaxel and zoledronic acid either as single agents or in sequence and combination. Cell viability and apoptosis were assessed along with the prenylation status of the GTPases Ras and RhoA. Following 1-mM zoledronic acid treatment, inhibition of the prenylation of H-Ras and Rho A was observed along with an increase in the unprenylated form in the cytoplasm. Docetaxel 1 nM and zoledronic acid 1 mM also showed an increase in the unprenylated form of both small GTP-binding proteins in the cytoplasm and a reduction of protein in the membrane fraction. Overall, zoledronic acid followed by docetaxel was the best regimen producing the greatest reduction in cell viability and increase in apoptosis. At the highest concentrations of zoledronic acid and docetaxel, zoledronic acid followed by docetaxel was also the most effective at reducing the prenylation of both H-Ras and RhoA at the membrane. We have demonstrated that clinically achievable concentrations of zoledronic acid and docetaxel cause a reduction in the prenylation of both H-Ras and Rho A and a reduction of protein movement into the membrane. The most effective regimen overall was high-dose zoledronic acid followed by docetaxel, suggesting that this regimen may be of benefit in clinical practice.
引用
收藏
页码:4861 / 4869
页数:9
相关论文
共 26 条
  • [1] Development of farnesyl transferase inhibitors: A review
    Appels, NMGM
    Beijnen, JH
    Schellens, JHM
    [J]. ONCOLOGIST, 2005, 10 (08) : 565 - 578
  • [2] Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation
    Coxon, JP
    Oades, GM
    Kirby, RS
    Colston, KW
    [J]. BJU INTERNATIONAL, 2004, 94 (01) : 164 - 170
  • [3] DANESI R, 1995, MOL PHARMACOL, V47, P1106
  • [4] New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects
    Denoyelle, C
    Hong, L
    Vannier, JP
    Soria, J
    Soria, C
    [J]. BRITISH JOURNAL OF CANCER, 2003, 88 (10) : 1631 - 1640
  • [5] Signal transduction in prostate cancer progression
    Gioeli, D
    [J]. CLINICAL SCIENCE, 2005, 108 (04) : 293 - 308
  • [6] Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells
    Goffinet, M
    Thoulouzan, M
    Pradines, A
    Lajoie-Mazenc, I
    Weinbaum, C
    Faye, JC
    Séronie-Vivien, S
    [J]. BMC CANCER, 2006, 6 (1)
  • [7] Synergistic Effect of Geranylgeranyltransferase Inhibitor, GGTI, and Docetaxel on the Growth of Prostate Cancer Cells
    Han, Bin
    Fujimoto, Naohiro
    Kobayashi, Mizuki
    Matsumoto, Tetsuro
    [J]. PROSTATE CANCER, 2012, 2012
  • [8] Consequences of mevalonate depletion - Differential transcriptional, translational, and post-translational up-reguiation of Ras, Rap1a, RhoA, and RhoB
    Holstein, SA
    Wohlford-Lenane, CL
    Hohl, RJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (12) : 10678 - 10682
  • [9] Bcl-2 phosphorylation required for anti-apoptosis function
    Ito, T
    Deng, XM
    Carr, B
    May, WS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (18) : 11671 - 11673
  • [10] The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel
    Jagdev, SP
    Coleman, RE
    Shipman, CM
    Rostami-H, A
    Croucher, PI
    [J]. BRITISH JOURNAL OF CANCER, 2001, 84 (08) : 1126 - 1134